Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24645 | 256 | 34.3 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LRIG1 | Author keyword | 51 | 83% | 11% | 29 |
| 2 | LRIG3 | Author keyword | 18 | 89% | 3% | 8 |
| 3 | LRIG2 | Author keyword | 14 | 100% | 3% | 7 |
| 4 | UROFACIAL SYNDROME | Author keyword | 12 | 75% | 4% | 9 |
| 5 | OCHOA SYNDROME | Author keyword | 12 | 86% | 2% | 6 |
| 6 | LRIG | Author keyword | 8 | 75% | 2% | 6 |
| 7 | LRRC4 | Author keyword | 8 | 60% | 4% | 9 |
| 8 | LIG 1 | Author keyword | 6 | 100% | 2% | 4 |
| 9 | UROFACIAL OCHOA SYNDROME | Author keyword | 6 | 100% | 2% | 4 |
| 10 | LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAINS 1 | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LRIG1 | 51 | 83% | 11% | 29 | Search LRIG1 | Search LRIG1 |
| 2 | LRIG3 | 18 | 89% | 3% | 8 | Search LRIG3 | Search LRIG3 |
| 3 | LRIG2 | 14 | 100% | 3% | 7 | Search LRIG2 | Search LRIG2 |
| 4 | UROFACIAL SYNDROME | 12 | 75% | 4% | 9 | Search UROFACIAL+SYNDROME | Search UROFACIAL+SYNDROME |
| 5 | OCHOA SYNDROME | 12 | 86% | 2% | 6 | Search OCHOA+SYNDROME | Search OCHOA+SYNDROME |
| 6 | LRIG | 8 | 75% | 2% | 6 | Search LRIG | Search LRIG |
| 7 | LRRC4 | 8 | 60% | 4% | 9 | Search LRRC4 | Search LRRC4 |
| 8 | LIG 1 | 6 | 100% | 2% | 4 | Search LIG+1 | Search LIG+1 |
| 9 | UROFACIAL OCHOA SYNDROME | 6 | 100% | 2% | 4 | Search UROFACIAL+OCHOA+SYNDROME | Search UROFACIAL+OCHOA+SYNDROME |
| 10 | LEUCINE RICH REPEATS AND IMMUNOGLOBULIN LIKE DOMAINS 1 | 3 | 100% | 1% | 3 | Search LEUCINE+RICH+REPEATS+AND+IMMUNOGLOBULIN+LIKE+DOMAINS+1 | Search LEUCINE+RICH+REPEATS+AND+IMMUNOGLOBULIN+LIKE+DOMAINS+1 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LIG 1 | 11 | 100% | 2% | 6 |
| 2 | NEGATIVE REGULATOR LRIG1 | 11 | 78% | 3% | 7 |
| 3 | OCHOA SYNDROME | 11 | 78% | 3% | 7 |
| 4 | DOMAIN PROTEINS LRIG1 3 | 6 | 100% | 2% | 4 |
| 5 | UROFACIAL SYNDROME | 4 | 67% | 2% | 4 |
| 6 | LRIG2 EXPRESSION | 4 | 75% | 1% | 3 |
| 7 | ERBB NEGATIVE REGULATOR | 4 | 56% | 2% | 5 |
| 8 | MOUSE NERVOUS SYSTEM | 4 | 32% | 4% | 10 |
| 9 | LRIG1 | 4 | 38% | 3% | 8 |
| 10 | 10Q23 Q24 | 3 | 100% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor | 2013 | 19 | 35 | 69% |
| LRIG and cancer prognosis | 2014 | 3 | 63 | 81% |
| AMIGO and friends: An emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs | 2006 | 52 | 68 | 38% |
| The LRIG family: enigmatic regulators of growth factor receptor signaling | 2014 | 1 | 77 | 66% |
| LRIG-inhibitors of growth factor signalling - double-edged swords in human cancer? | 2007 | 44 | 44 | 36% |
| Clinical and genetic characteristics for the Urofacial Syndrome (UFS) | 2014 | 1 | 27 | 52% |
| Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation | 2014 | 1 | 40 | 43% |
| Progress in LRRC4, a novel brain-specific gene glioma suppressive gene | 2007 | 2 | 13 | 69% |
| Can a congenital dysfunctional bladder be diagnosed from a smile? The Ochoa syndrome updated | 2004 | 36 | 26 | 27% |
| Function and mechanism of tumor suppressor gene LRRC4/NGL-2 | 2014 | 0 | 55 | 33% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SINOGERMAN NEUROONCOL MOL | 2 | 67% | 0.8% | 2 |
| 2 | SINO GERMAN NEUROONCOL MOL | 1 | 100% | 0.8% | 2 |
| 3 | UNIV HOSP SAN VINCENTE DE PAUL | 1 | 100% | 0.8% | 2 |
| 4 | CELL SUR E SIGNALLING | 1 | 17% | 2.3% | 6 |
| 5 | MINIST EDUC CARCINOGENESISMINIST HLTH | 1 | 40% | 0.8% | 2 |
| 6 | INITIAT IMMUNOL FRONTIER | 1 | 50% | 0.4% | 1 |
| 7 | INTERNAL MED CARDIOVASC P MEDCHUO | 1 | 50% | 0.4% | 1 |
| 8 | MAMMALIAN GENET DIABET EXCELLENCE | 1 | 50% | 0.4% | 1 |
| 9 | MINIST EDUCMINIST HLTHCANC | 1 | 50% | 0.4% | 1 |
| 10 | ORTHOPAED SURG CAMPBELL CLIN PATHOL | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000140737 | LEUCINE RICH ALPHA 2 GLYCOPROTEIN 1//GLOBAL OLARS PROGRAM//LRG1 |
| 2 | 0.0000101523 | MIG 6//ACK1//RALT |
| 3 | 0.0000097528 | FLIGHTLESS I//TTYH1//TWEETY |
| 4 | 0.0000096544 | NEUROLIGIN//SHANK3//NEUREXIN |
| 5 | 0.0000077935 | RLGS//RESTRICTION LANDMARK GENOMIC SCANNING//GENOMIC SCANNING |
| 6 | 0.0000076990 | HER3//NUCLEAR EGFR//EGFR FAMILY |
| 7 | 0.0000062576 | NGX6//BRD7 GENE//NGX6 GENE |
| 8 | 0.0000054524 | ODZ//TEN M//TENEURIN |
| 9 | 0.0000052462 | NIMOTUZUMAB//H R3//CETUXIMAB |
| 10 | 0.0000051482 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |